Learn More
Invitrogen™ GM-CSF Monoclonal Antibody (1089)
Description
M501 targets Human GM-CSF in ELISA applications and shows reactivity with Human samples. The M501 immunogen is glycosylated, CHO-derived recombinant human GM-CSF. M501 detects Human GM-CSF which has a predicted molecular weight of approximately 14 kDa. This product has been tested for endotoxins by limulus amoebocyte lysate (LAL) assay and contains an endotoxin concentration of less than or equal to 10 endotoxin units per milligram (EU/mg).
Specifications
Specifications
| Antigen | GM-CSF |
| Applications | ELISA |
| Classification | Monoclonal |
| Clone | 1089 |
| Concentration | 1.0 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative |
| Gene | CSF2 |
| Gene Accession No. | P04141 |
| Gene Alias | colony stimulating factor 2; colony stimulating factor 2 (granulocyte-macrophage); colony-stimulating factor; CSF; CSF2; Csfgm; cytokine; GMCSF; Gm-CSf; granulocyte macrophage colony stimulating factor; granulocyte macrophage-colony stimulating factor; granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor; MGC131935; MGC138897; MGC151255; MGC151257; MGI-IGM; M-GM-CSF; molgramostin; put. GM-CSF; sargramostim |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.